E. Mallah et al. / Tetrahedron 68 (2012) 1005e1010
1009
then filtered off and dried in vacuo. The product was purified by
crystallisation from CH2Cl2/diethylether to give 18 (1.58 g, 86%) as
colourless crystals. dH (250 MHz, CDCl3) 3.06 (s, 6H, 1,3-MeB), 1.43
(d, J¼6.8 Hz, 12H, 1,3-CHMe2), 2.16 (s, 6H, 4,5-Me), 4.78 (sept, 2H,
CHMe2); dC (62.5 MHz, CDCl3) 30.6 (1,3-MeB), 151.6 (C2B), 114.2
(C5B), 158.2 (C4,6B), 9.8 (4,5-Me), 20.2 (1,3-CHMe2), 52.6 (1,3-
CHMe2), 126.3 (C4,5), 127.9 (C2). Anal. Calcd for C17H26ClN5O5: C
49.10, H 6.30, N 16.84. Found C 49.39, H 6.02, N 16.71. MS (FAB), m/z:
215 [100, Mþ], 173 [14, MþꢀC3H7], 136 [23, Mþꢀ(C3H7), ꢀCl] and
further fragments.
4.2.5. 5,6-Dihydro-1,3-dimethyl-5,6-bis-[10,30-dimethyl]-20,40,60-tri-
oxopyrimid (50,50) yl[2,3-d] uracil (21). A solution of 8 (0.53 g,
2.9 mmol) in diethylether (10 mL) was cooled to ꢀ78 ꢁC, then was
added to 13 (0.65 g, 2.9 mmol) in diethylether (25 mL). After that,
the reaction mixture was allowed to stir at room temperature
overnight, and then the precipitate was filtered off, washed with
CH2Cl2 and dried in vacuo. The product was purified by crystal-
lisation from CH2Cl2/diethylether to give 21 (1.11 g, 83%) as col-
ourless crystals. dH (250 MHz, DMSO-d6) 3.26e3.29e3.52 (s,s,s,
6,9,3H,1,3-MeB). Anal. Calcd for C18H19N6O9: C 46.76, H 3.92, N
18.18. Found C 46.91, H 3.60, N 18.52. MS (FAB), m/z: 215 [100, Mþ],
173 [18, MþꢀC3H7], 136 [20, Mþꢀ(C3H7), ꢀCl] and further
fragments.
Fig. 7. View of the trimer in 21 with atomic numbering scheme.
1,3-dimethylbarbituric acid (1a) (1.40 g, 9.0 mmol) in THF (25 mL)
was refluxed at 85 ꢁC for 6 h. After cooling to room temperature, the
solvent was removed in vacuo and the residue recrystallised from
CH2Cl2/diethylether to give dichloro compound 13 (1.72 g, 85%) as
colourless crystals. dH (250 MHz, CDCl3) 3.30 (s, 6H, 1,3-Me); dC
(62.5 MHz, CDCl3) 30.7 (1,3-Me), 149.1 (C2), 72.2 (C5), 161.7 (C4,6).
Anal. Calcd for C6H6Cl2N2O3: C 32.02, H 2.69, N 12.45. Found C
32.25, H 2.51, N 12.68. MS (FAB), m/z: 225 [93, Mþ], 191 [100,
MþꢀCl] and further fragments.
4.3. X-ray crystallographic data
Suitable crystals for crystallographic investigations of 13, 14, 17
and 18 were obtained by slow diffusion of ether into CH2Cl2 solu-
tion. A crystal of 21 was obtained by slow evaporation of a solution
of 15.0 mg of 21 in methanol (5 mL). X-ray measurements for
synthesized compounds were carried out on a glass fibre with
epoxy cement at room temperature. Preliminary examination and
data collection were performed with a Stoe CAD4 and IPDS 2 dif-
4.2.2. 5-Chloro-1,3-dimethyl-5-nitro-2,4,6(1H,3H,5H)-pyrimidine-
trione (14). To a solution of 13 (0.80 g, 3.6 mmol) in acetonitrile
(30 mL), silver nitrite was added (1.25 g, 8.1 mmol) in one portion at
room temperature. The reaction mixture was allowed to stir at
room temperature overnight. Thereafter, the solvent was evapo-
rated in vacuo and the residue dissolved in CH2Cl2 (15 mL) and
filtered off. The CH2Cl2 filtrate was evaporated under reduced
pressure whereby a powder residue was obtained. It was purified
by crystallisation from CH2Cl2/diethylether to afford 14 (0.62 g,
73%) as colourless crystals. dH (250 MHz, CDCl3) 3.34 (s, 6H,1,3-Me);
dC (62.5 MHz, CDCl3) 30.6 (1,3-Me), 149.2 (C2), 89.2 (C5), 159.1
(C4,6). Anal. Calcd for C6H6ClN3O5: C 30.59, H 2.57, N 17.84. Found C
30.78, H 2.43, N 17.62. MS (FAB), m/z: 189 [6, MþꢀNO2], 161 [100,
MþꢀNO2ꢀ2Me] and further fragments.
fractometer with graphite-monochromated Mo
K
a
radiation
ꢀ
ꢀ
(l¼0.71073 A) and Cu K
a radiation (l¼1.54184 A). The structures
were solved by direct methods and refined by full-matrix least-
squares on F2 using SHELXS-9742 and SHELXTL V5.1 (NT). Details for
the structure solutions and refinements are given in Table 1 (Sup-
plementary data).
Acknowledgements
Financial support by the Deutsche Forschungsgemeinschaft and
the Higher Council for Science and Technology of Jordan is grate-
€
€
fully acknowledged. We also thank Dr. Cacilia Maichle-Moßmer for
her help with the X-ray measurements.
4.2.3. Potassium 5-cyano-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-
4-pyrimidinolate 1,4,7,10,13,16-hexaoxacyclooctadecane (17). To
a mixture of potassium cyanide (0.35 g, 5.4 mmol) and 18-crown-6
(0.93 g, 3.5 mmol) in CH2Cl2 (15 mL), a solution of 13 (0.40 g,
1.8 mmol) in CH2Cl2 (15 mL) was added. After being stirred at room
temperature overnight, the reaction mixture was concentrated in
vacuo. The resulting residue was recrystallised from CH2Cl2/dieth-
ylether to give 17 (0.48 g, 55%) as yellow crystals. dH (250 MHz,
CDCl3) 3.51 (s, 6H, 1,3-MeB), 3.65 (s, 12H, crown ether); dC
(62.5 MHz, CDCl3) 30.6 (1,3-MeB), 41.4 (C5B), 109.4 (CN), 154.3
(C2B), 165.1 (C4,6B). Anal. Calcd for C19H30N3O9K: C 47.19, H 6.25, N
8.69. Found C 47.43, H 6.24, N 8.98. MS (FAB), m/z: 180 [100, Mþ]
and further fragments.
Supplementary data
Supplementary crystallographic data associated with this article
(CCDC 842202, CCDC 842203, CCDC 842204, CCDC 842205 and
CCDC 842380) can be found free of charge from The Cambridge
request/cif. In addition, crystal data and structure refinement for
C6H6Cl2N2O3 (13), C6H6ClN3O5 (14), C19H30N3O9K (17),
C17H26ClN5O5 (18), and C18H19N6O9 (21) are contained in the Sup-
plementary data. Supplementary data related to this article can be
4.2.4. 2-Chloro-1,3-diisopropyl-4,5-dimethyl-1H-imidazol-3-ium
1,3-dimethyl-5-nitro-2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinolate
(18). A solution of 8 (0.80 g, 4.4 mmol) in diethylether (10 mL) was
cooled to ꢀ78 ꢁC, then added to a solution of 14 (1.04 g 4.4 mmol)
in diethylether (25 mL). Thereafter, the reaction mixture was
allowed to stir at room temperature overnight. The precipitate was
References and notes
1. Habibi, A.; Tarameshloo, Z. J. Iran. Chem. Soc. 2011, 8, 287e291.
2. Rastaldo, R.; Penna, C.; Pagliaro, P. Life Sci. 2001, 69, 729e738.
3. Jursic, B. S.; Stevens, D. E. J. Heterocycl. Chem. 2003, 40, 701e706.
4. Wolff, M. E. Burger’s Medicinal Chemistry and Drug Discovery; Wiley: New York,
NY, 1997.